A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
Clinical trial NCT05279300 · SUSPENDED
Trial details
- NCT number
- NCT05279300
- Sponsor
- CStone Pharmaceuticals
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2027-06-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.